|
|
|
Clinical TrialsOvarian CancerAdvancedEndocyte EC-FV-02. A Phase II study of EC145 in patients with advance ovarian and endometrial cancers. [UCLA]
For more information on VCHOS trials, please call Ruth Ann Begun, OCN at (805) 485-8709 ext 136 or email at rbegun@venturaoncology.comFor more information on UCLA network trials, please call Pamela Riach, RN at (805) 485-8709 ext 129 or email at priach@mednet.ucla.edu.
|
|
Send mail to
webmaster@venturaoncology.com with
questions or comments about this web site.
|